Shambavi Richard
- Oncology top 10%
- Hematology top 5%
- Molecular Biology
- Immunology
- Radiology, Nuclear Medicine and Imaging
- Co-authors
- Joshua RichterSundar JagannathDeepu MadduriHearn Jay ChoSamir ParekhAjai ChariLarysa SanchezGuido Lancman
- Topics
- Multiple Myeloma Research and Treatments (47 papers)CAR-T cell therapy research (25 papers)Protein Degradation and Inhibitors (14 papers)
- Cited by
- HematologyOncologyGenetics
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Shambavi Richard
57 papers receiving 702 citations
Peers
Comparison fields: 5 of 101
- Oncology 394
- Hematology 353
- Molecular Biology 268
- Immunology 114
- Radiology, Nuclear Medicine and Imaging 99
Countries citing papers authored by Shambavi Richard
This map shows the geographic impact of Shambavi Richard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shambavi Richard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shambavi Richard more than expected).
Fields of papers citing papers by Shambavi Richard
This network shows the impact of papers produced by Shambavi Richard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shambavi Richard. The network helps show where Shambavi Richard may publish in the future.
Co-authorship network of co-authors of Shambavi Richard
This figure shows the co-authorship network connecting the top 25 collaborators of Shambavi Richard. A scholar is included among the top collaborators of Shambavi Richard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shambavi Richard. Shambavi Richard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 1 | |
| 5 | 2 | |
| 6 | 0 | |
| 7 | 1 | |
| 8 | 1 | |
| 9 | 1 | |
| 10 | 0 | |
| 11 | 56 | |
| 12 | 2 | |
| 13 | 14 | |
| 14 | 9 | |
| 15 | 18 | |
| 16 | 6 | |
| 17 | 1 | |
| 18 | 38 | |
| 19 | 4 | |
| 20 | 14 |
About Shambavi Richard
Shambavi Richard is a scholar working on Hematology, Oncology and Genetics, having authored 64 papers that have together received 708 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (47 papers), CAR-T cell therapy research (25 papers) and Protein Degradation and Inhibitors (14 papers). The work is most often cited by research in Hematology (353 citations), Oncology (394 citations) and Genetics (60 citations). Shambavi Richard has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Joshua Richter, Sundar Jagannath, Deepu Madduri, Hearn Jay Cho, Samir Parekh, Ajai Chari, Larysa Sanchez, Guido Lancman, Cesar Rodriguez and Santiago Thibaud. Their work appears in journals such as Journal of Clinical Oncology, Blood and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.